Dr. Agarwals Eye Hospital Reports Strong Financial Growth Amid Rising Interest Expenses

Dr. Agarwals Eye Hospital has recently undergone a financial trend adjustment, reflecting a notable improvement in its performance metrics for the quarter ending March 2025. The company's net sales reached Rs 99.83 crore, marking a growth of 23.67%. This robust sales performance is complemented by a record PBDIT of Rs 31.59 crore and an operating profit to net sales ratio of 31.64%, indicating strong operational efficiency.
Additionally, the profit before tax, excluding other income, stood at Rs 18.50 crore, growing by 24.33%, while the profit after tax reached Rs 15.99 crore. The earnings per share also hit a high of Rs 34.02, showcasing the company's profitability.

However, the company faces challenges, particularly with interest expenses, which have surged to Rs 10.41 crore, reflecting a significant growth of 51.09% over the past nine months.

In terms of market performance, Dr. Agarwals Eye Hospital has shown resilience compared to the Sensex. Over the past year, the stock has returned 39.94%, significantly outperforming the Sensex's 8.17% return. Over three years, the stock has surged by 557.18%, while the Sensex has increased by 48.15%. This performance highlights the company's strong recovery and competitive positioning in the healthcare sector.